Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Biotechnology Business
Robert Fildes, Former President of Biogen and Cetus, Joins Vaxart Board
April 2nd, 2008
Vaxart, Inc., a biotechnology company focused on the development of oral vaccines, announced that Robert Fildes, PhD, has been appointed to the board of directors. "We're very pleased that Bob has come on board," said Mark Backer, PhD, the company's CEO. "His operational experience and track record in growing biotech companies will be an incredible asset as we prepare to move our first product into the clinic." Fildes has had a long and illustrious career in the biotech industry. In the early 1980s, he was a founder and president of Biogen Inc. He then went on to become CEO of Cetus Corp., where he built the company into a leader in PCR and brought...
Source: Vaccine Weekly (2008-04-02)
|
